Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Reports outline cervical cancer study results from Catholic University
July 31st, 2008
"Aim of this study is to evaluate the feasibility of an accelerated fractionation radiotherapy by concomitant boost in locally advanced cervical cancer patients, to explore the maximum tolerated dose (MTD) of radiation through a dose-escalation scheme, and to verify if increasing the radiation dose would result in a higher rate of pathologic complete response. During the first and the last week of treatment, a combination of cisplatin (20 mg/mq/d, IV, days 1-4) and 5-fluorouracil (1g/mq/d, continuous venous infusion, days 1-4) was administered," researchers in Rome, Italy report. "The dose escalation of external radiotherapy was delivered on the primary tumor, using the...
Source: Women's Health Weekly (2008-07-31)
|
